ArticleNature2025
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors.
Shilpa Singh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ArticleNature2025
Shilpa Singh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.